Skip to main content

Advertisement

Log in

Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases

  • Review
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

The failure of mechanisms of natural anti-coagulation either due to genetic impairment or due to severe external injuries may result in a condition called thrombosis. This is believed to be the primary cause for a variety of life-threatening conditions such as: heart attack, stroke, pulmonary embolism, thrombophlebitis, and deep venous thrombosis (DVT). The growing number of these incidents requires an alternative anti-coagulant or anti-thrombotic agent that has minimal side effects and improved efficiency. For decades, plant polyphenols, especially flavonoids, were known for their vital role in preventing various diseases such as cancer. Mitigating excessive oxidative stress caused by reactive oxygen species (ROS) with anti-oxidant-rich flavonoids may reduce the risk of hyper-activation of platelets, cardiovascular diseases (CVD), pain, and thrombosis. Furthermore, flavonoids may mitigate endothelial dysfunction (ED), which generally correlates to the development of coronary artery and vascular diseases. Flavonoids also reduce the risk of atherosclerosis and atherothrombotic disease by inhibiting excessive tissue factor (TF) availability in the endothelium. Although the role of flavonoids in CVD is widely discussed, to the best of our knowledge, their role as anti-thrombotic lead has not been discussed. This review aims to focus on the biological uses of dietary flavonoids and their role in the treatment of various coagulation disorders, and may provide some potential lead to the drug discovery process in this area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

AA:

Arachidonic acid

ACS:

Acute coronary syndrome

aPTT:

Activated partial thromboplastin time

ASA:

Acetylsalicylic acid

CEP 350:

Centrosome-associated protein 350

COX-1:

Cyclooxygenase-1

CVD:

Cardiovascular diseases

DNBS:

Dinitrobenzene sulfonic acid

DVT:

Deep venous thrombosis

ED:

Endothelial dysfunction

HNE:

4-Hydroxy-2-nonenal

MAPKs:

Mitogen-activated protein kinases

NAC:

N-acetylcysteine

NO:

Nitric oxide

PMQ:

Pentamethylquercetin

PON2:

Protein paraoxonase 2

PT:

Prothrombin time

ROS:

Reactive oxygen species

SNI:

Spared nerve injury

SOD:

Superoxide dismutase

TBARS:

Thio-barbituric acid reactive species

TF:

Tissue factor

TiO2 :

Titanium dioxide

TxA2 :

Thromboxane A2

VTE:

Venous thromboembolism

References

Download references

Funding

This work received no external funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajan Radhakrishnan.

Ethics declarations

Conflict of interest

Authors declare that there is no conflict of interest on this review article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vazhappilly, C.G., Ansari, S.A., Al-Jaleeli, R. et al. Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases. Inflammopharmacol 27, 863–869 (2019). https://doi.org/10.1007/s10787-019-00612-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-019-00612-6

Keywords

Navigation